2022 American Transplant Congress
On the Circuit: Intra-Operative CRRT in Pediatric Liver Transplant Recipients with Acute Kidney Injury
*Purpose: Acute renal failure is common in pediatric patients undergoing liver transplantation (LT), with an incidence of 17-55%. Fluid, metabolic and acid-base aberrancies are often…2022 American Transplant Congress
Daratumumab Therapy Achieves Dialysis Independence in Kidney Transplant Recipients with Resistant Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits
The Ohio State University, Columbus, OH
*Purpose: Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is a unique cause for monoclonal gammopathy of renal significance with overall poor prognosis. Patients are frequently…2022 American Transplant Congress
Meta-Analysis of the Chronic Exposure to Calcineurin Inhibitors and the Risk for Chronic and End-Stage Kidney Disease in Non-Renal Solid Organ Transplant Recipients
*Purpose: Calcineurin inhibitors (CNI) are standard of care immunosuppressants among all solid organ transplant (SOT) recipients, and the most common side effect is nephrotoxicity. There…2022 American Transplant Congress
Re-Examining the Optimal Threshold for Donor Derived Cell Free DNA in Renal Allograft Rejection
*Purpose: Due to the invasive nature and potential complications of allograft biopsies, there is an important role for surrogate biomarkers to help identify rejection early,…2021 American Transplant Congress
Chances of Renal Recovery in Liver Only Transplant Recipients Who Were Eligible for Simultaneous Liver-Kidney Transplant
*Purpose: Progressive decline in renal function is common among patients with end-stage liver disease. Liver transplant (LT) candidates can often develop severely impaired renal function…2021 American Transplant Congress
Temporal Changes in Renal Function Predict Waitlist Death or Deterioration in Pediatric Liver Transplantation
Mayo Clinic Rochester, Minnesota, Rochester, MN
*Purpose: Renal dysfunction at the time of listing predicts inferior waitlist outcomes in pediatric liver transplant candidates, independent of the Pediatric End-Stage Liver Disease (PELD)…2021 American Transplant Congress
Therapeutic Enoxaparin Dosing in Lung Transplant Recipients
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Enoxaparin 1 mg/kg subcutaneously every 12 hours for therapeutic anticoagulation is known to increase rates of supratherapeutic anti-Xa levels in lung transplant recipients (LTRs).…2021 American Transplant Congress
Assessing the Impact of Acute Major Adverse Kidney Events on Clinical Outcomes in Heart Transplant Recipients
1Pharmacy, MUSC Health, Charleston, SC, 2Medicine, MUSC Health, Charleston, SC
*Purpose: The purpose of this study was to elucidate contributors to the Major Adverse Kidney Events at 30 days (MAKE-30) outcome in heart transplant recipients…2021 American Transplant Congress
Pre Transplant Estimated Glomerular Filtration Rate and Other Predictors of Mortality and End Stage Kidney Disease After Lung Transplantation
*Purpose: Lung transplantation is an established treatment for end stage lung disease and as survival has improved, chronic kidney disease (CKD) has become a common…2021 American Transplant Congress
The Trifecta Study: Calibrating Circulating Donor-Derived Cell-Free DNA at the Time of Indication Biopsies Against the Molecular Phenotype of the Biopsy Reveals a Prominent Association with NK Cell Genes
1Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, 2Natera Inc., San Carlos, CA
*Purpose: The international, multicenter, prospective Trifecta study was designed to calibrate dd-cfDNA% measurements in blood at the time of indication biopsy against the molecular characteristics…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 17
- Next Page »